Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice.
Lee SH, Cho SY, Yoon Y, Park C, Sohn J, Jeong JJ, Jeon BN, Jang M, An C, Lee S, Kim YY, Kim G, Kim S, Kim Y, Lee GB, Lee EJ, Kim SG, Kim HS, Kim Y, Kim H, Yang HS, Kim S, Kim S, Chung H, Moon MH, Nam MH, Kwon JY, Won S, Park JS, Weinstock GM, Lee C, Yoon KW, Park H. Lee SH, et al. Among authors: lee ej, lee gb, lee s, lee c. Nat Microbiol. 2021 Mar;6(3):277-288. doi: 10.1038/s41564-020-00831-6. Epub 2021 Jan 11. Nat Microbiol. 2021. PMID: 33432149
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor.
Kim Y, Kim CH, Lee HY, Lee SH, Kim HS, Lee S, Cha H, Hong S, Kim K, Seo SW, Sun JM, Ahn MJ, Ahn JS, Park K. Kim Y, et al. Among authors: lee sh, lee hy, lee s. J Thorac Oncol. 2019 Sep;14(9):1608-1618. doi: 10.1016/j.jtho.2019.05.033. Epub 2019 Jun 11. J Thorac Oncol. 2019. PMID: 31195179 Free article.
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer.
Koh J, Kim S, Woo YD, Song SG, Yim J, Han B, Lim S, Ahn HK, Mun S, Kim JS, Keam B, Kim YA, Lee SH, Jeon YK, Chung DH. Koh J, et al. Among authors: lee sh. Eur J Cancer. 2022 Oct;174:10-20. doi: 10.1016/j.ejca.2022.07.004. Epub 2022 Aug 12. Eur J Cancer. 2022. PMID: 35970031 Free article.
Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
Park C, Jeong DY, Choi Y, Oh YJ, Kim J, Ryu J, Paeng K, Lee SH, Ock CY, Lee HY. Park C, et al. Among authors: lee sh, lee hy. Front Immunol. 2023 Jan 5;13:1038089. doi: 10.3389/fimmu.2022.1038089. eCollection 2022. Front Immunol. 2023. PMID: 36660547 Free PMC article.
Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Bae HM, Min HS, Lee SH, Kim DW, Chung DH, Lee JS, Kim YW, Heo DS. Bae HM, et al. Among authors: lee sh, lee js. Lung Cancer. 2007 Oct;58(1):112-5. doi: 10.1016/j.lungcan.2007.05.006. Epub 2007 Jun 18. Lung Cancer. 2007. PMID: 17574296
23,522 results
You have reached the last available page of results. Please see the User Guide for more information.